The Prognostic Significance of Radiographic Progression Without PSA Progression in Patients With Metastatic Hormone‐Sensitive Prostate Cancer Treated With First‐Line ARPI Therapy

Documenti analoghi

• Comparison of Oncological Outcomes of Conventional Androgen Deprivation Therapy ( ADT ) and ADT Plus Androgen Receptor Signaling Inhibitor in Older Patients With Metastatic Castration‐Sensitive Prostate Cancer
  di: Yutaka Yamamoto, et al.
  Pubblicazione: (2025)
• Comparative Efficacy of First‐Line Immune Checkpoint Inhibitor‐Based Combination Therapies in Patients With Sarcomatoid Renal Cell Carcinoma: A Japanese Multicenter Cohort Study
  di: Keita Tamura, et al.
  Pubblicazione: (2026)
• Role of Cytoreductive Nephrectomy in the Immune Checkpoint Inhibitor Era: A Multicenter Collaborative Study
  di: Takuhisa Nukaya, et al.
  Pubblicazione: (2025)
• Treatment Strategies for Metastatic Castration‐Sensitive Prostate Cancer: Current Evidence and Future Directions
  di: Kiyoshi Takahara, et al.
  Pubblicazione: (2026)
• Impact of Estimated Glomerular Filtration Rate and Serum C‐Reactive Protein Level to Overall Survival After Second‐Line Targeted Therapy Following Immuno‐Oncology Combination Therapy for Advanced Renal Cell Carcinoma
  di: Keita Nakane, et al.
  Pubblicazione: (2025)